
Article 1 
Annex XVII to Regulation (EC) No 1907/2006 is amended in accordance with the Annex.
Article 2 

1. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
2. It shall apply from the date of entry into force, with the exception of:
— paragraphs (1), (2) and (3) of the Annex, which shall apply on 1 March 2018, and
— paragraph (4)(a) of the Annex which shall apply on 1 March 2018 to the extent that it relates to the following substances:
bisphenol A; [phenol, dodecyl-, branched]; [phenol, 2-dodecyl-, branched]; [phenol, 3-dodecyl-, branched]; [phenol, 4-dodecyl-, branched]; [phenol, (tetrapropenyl) derivatives]; chlorophacinone (ISO); coumatetralyl (ISO); difenacoum (ISO); flocoumafen (ISO); disodium octaborate anhydrous; disodium octaborate tetrahydrate; bromadiolone (ISO); difethialone; [perfluorononan-1-oic acid, and its sodium and ammonium salts]; dicyclohexyl phthalate and triflumizole (ISO).
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 30 August 2017.
For the Commission
The President
Jean-Claude JUNCKER
ANNEX

Annex XVII to Regulation (EC) No 1907/2006 is amended as follows:

((1)) in Appendix 2, the following entries are inserted in the table in order of the index numbers set out therein:
'
1,2-dichloropropane; propylene dichloride 602-020-00-0 201-152-2 78-87-5 
e-glass microfibers of representative composition; [Calcium-aluminium-silicate fibres with random orientation with the following representative composition (% given by weight): SiO2 50,0-56,0 %, Al2O3 13,0-16,0 %, B2O3 5,8-10,0 %, Na2O < 0,6 %, K2O < 0,4 %, CaO 15,0-24,0 %, MgO < 5,5 %, Fe2O3 < 0,5 %, F2 < 1,0 %. Process: typically produced by flame attenuation and rotary process. (Additional individual elements may be present at low levels; the process list does not preclude innovation).] 014-046-00-4 — — '
((2)) in Appendix 4, the following entry is inserted in the table in order of the index number set out therein:
'
3,7-dimethylocta-2,6-dienenitrile 608-067-00-3 225-918-0 5146-66-7 '
((3)) in Appendix 5,

((a)) the following entries are inserted in the table in order of the index numbers set out therein:
'
brodifacoum (ISO);4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin 607-172-00-1 259-980-5 56073-10-0 
lead powder;[particle diameter < 1 mm] 082-013-00-1 231-100-4 7439-92-1 
lead massive:[particle diameter ≥ 1 mm] 082-014-00-7 231-100-4 7439-92-1 '
((b)) the entry relating to warfarin; 4-hydroxy-3-(3-oxo-1- phenylbutyl)-coumarin is replaced by the following entry:
'
warfarin (ISO);4-hydroxy-3-(3-oxo-1- phenylbutyl)-2H-chromen-2-one; [1](S)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone; [2](R)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone [3] 607-056-00-0 201-377-6 [1]226-907-3 [2]226-908-9 [3] 81-81-2 [1]5543-57-7 [2]5543-58-8 [3] '
((4)) in Appendix 6,

((a)) the following entries are inserted in the table in order of the index numbers set out therein:
'
tetrahydro-2-furyl-methanol; tetrahydrofurfuryl alcohol 603-061-00-7 202-625-6 97-99-4 
gallium arsenide 031-001-00-4 215-114-8 1303-00-0 
Tributyltin compounds, with the exception of those specified elsewhere in this Annex 050-008-00-3 — — 
1,2-benzenedicarboxylic acid, dihexyl ester, branched and linear 607-710-00-5 271-093-5 68515-50-4 
imidazole 613-319-00-0 206-019-2 288-32-4 
bisphenol A; 4,4′-isopropylidenediphenol 604-030-00-0 201-245-8 80-05-7 
phenol, dodecyl-, branched; [1]phenol, 2-dodecyl-, branched; [2]phenol, 3-dodecyl-, branched; [3]phenol, 4-dodecyl-, branched; [4]phenol, (tetrapropenyl) derivatives [5] 604-092-00-9 310-154-3 [1]- [2]- [3]- [4]- [5] 121158-58-5 [1]- [2]- [3]210555-94-5 [4]74499-35-7 [5] 
chlorophacinone (ISO);2-[(4-chlorophenyl)(phenyl)acetyl]-1H-indene-1,3(2H)-dione 606-014-00-9 223-003-0 3691-35-8 
coumatetralyl (ISO); 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin 607-059-00-7 227-424-0 5836-29-3 
difenacoum (ISO); 3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin 607-157-00-X 259-978-4 56073-07-5 
flocoumafen (ISO); reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin and trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin 607-375-00-5 421-960-0 90035-08-8 
disodium octaborate anhydrous; [1]disodium octaborate tetrahydrate [2] 005-020-00-3 234-541-0 [1]234-541-0 [2] 12008-41-2 [1]12280-03-4 [2] 
bromadiolone (ISO); 3-[3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2H-chromen-2-one 607-716-00-8 249-205-9 28772-56-7 
difethialone (ISO);3-[3-(4′-bromobiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-hydroxy-2H-1-benzothiopyran-2-one 607-717-00-3 — 104653-34-1 
perfluorononan-1-oic acid [1]and its sodium [2]and ammonium [3] salts 607-718-00-9 206-801-3 [1]- [2]- [3] 375-95-1 [1]21049-39-8 [2]4149-60-4 [3] 
dicyclohexyl phthalate 607-719-00-4 201-545-9 84-61-7 
triflumizole (ISO);(1E)-N-[4-chloro-2-(trifluoromethyl)phenyl]-1-(1H-imidazol-1-yl)-2-propoxyethanimine 612-289-00-6 — 68694-11-1 '
((b)) the entry relating to flumioxazin (ISO); N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl)—2,H 1,4-benzoxazin-6-yl) cyclohex-1-ene-1,2dicarboxamide is replaced by the following entry:
'
flumioxazin (ISO); 2-[7-fluoro-3-oxo-4- (prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-1,3 (2H)-dione 613-166-00-X — 103361-09-7 '
